Recombinant cytokines as immunological adjuvants
- 1 October 1993
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 71 (5) , 367-379
- https://doi.org/10.1038/icb.1993.43
Abstract
This paper describes the bacterial expression and purification of bioactive recombinant ovine interleukin-2 (rovIL-2), interleukin-l (rovlL-l) and tumour necrosis factor . These purified proteins had specific activities in appropriate bioassays of 1 107, 1 times; 107 and 1 105 U/mg, respectively. Recombinant ovIL-l was assessed as an immunological adjuvant for the sheep response to the model protein avidin. When delivered either intradermally or intramuscularly in conjunction with avidin in aluminium hydroxide the rovIL-1 significantly enhanced the secondary humoral response. Doses of 1, 10 or 100 g per sheep enhanced the humoral response to a similar extent. Recombinant ovIL-1 had similar adjuvant activity in that it was demonstrated to significantly enhance the sheep humoral response to an experimental H. contortus antigen. This increase in specific antibody, however, did not correlate with enhanced protection against infection with third stage H. contortus larvae. In addition incorporation of rovIL-1 P into the formulation was shown not to alter the isotype profile of H. contortus antigen specific antibody.Keywords
This publication has 34 references indexed in Scilit:
- Towards a comprehensive view of immunoglobulin class switchingImmunology Today, 1993
- Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?Immunology Today, 1992
- Endothelial cell interactions with granulocytes: tethering and signaling moleculesImmunology Today, 1992
- Regulation and biological function of helminth-induced cytokine responsesImmunology Today, 1991
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infectionVeterinary Immunology and Immunopathology, 1989
- Differences in the synthesis and kinetics of release of interleukin 1α, interleukin 1β and tumor necrosis factor from human mononuclear cellsEuropean Journal of Immunology, 1989
- Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responsesCellular Immunology, 1989
- There is more than one interleukin 1Immunology Today, 1986
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984